Anavex Life Sciences Corp (AVXL)

[Jonjones325]

Thanks.

I’m having a hard time understanding why our Alz data doesn’t virtually guarantee us getting AA.

We met the definition of a successful trial with the one primary and our secondary. We have the gold standard biomarker that the Mabs were approved with.

We have the reduction in brain atrophy and safety to boot. On what grounds could the FDA deny us?

Small trial? I thought these results were harder to get with a small trial thus our signal is stronger.

All said before but the decision seems straightforward. Even without the ADL data since elements of ADL are seen within the CDR. Not sure what there is not to like.

All I see is winning!